Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R3VQ
|
|||
| Former ID |
DIB012109
|
|||
| Drug Name |
BAL-27862
|
|||
| Synonyms |
Tubulin interacting agent (oral, cancer), Basilea
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
| Company |
Basilea Pharmaceutica International Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C20H17N7O2
|
|||
| Canonical SMILES |
C1=CC=C2C(=C1)N=C(N2CC(=O)C3=CC=C(C=C3)N)C4=NON=C4NCCC#N
|
|||
| InChI |
1S/C20H17N7O2/c21-10-3-11-23-19-18(25-29-26-19)20-24-15-4-1-2-5-16(15)27(20)12-17(28)13-6-8-14(22)9-7-13/h1-2,4-9H,3,11-12,22H2,(H,23,26)
|
|||
| InChIKey |
LSFOZQQVTWFMNS-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 798577-91-0
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.